Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

Pfizer

Status and phase

Completed

Phase 3

Conditions

Bacteremia

Gram-Positive Bacterial Infections

Bacterial Infections

Treatments

Drug: Linezolid

Drug: Dicloxacillin

Drug: Oxacillin

Drug: Vancomycin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00037050

A5951060

M12600080

Details and patient eligibility

About

This study will treat patients who have a short term central catheter that is thought to be infected with a specific bacteria (gram positive bacteria)

Enrollment

739 patients

Sex

All

Ages

13+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with a central indwelling catheter with signs and symptoms of infection

Exclusion criteria

Patients with tunneled catheter which cannot be removed.
Patients with evidence of endovascular infection including endocarditis.
Patients with infection of permanent intravascular devices.
Patients who have received more than 1 day of another antibiotic before enrollment.
Patients with HIV and low CD4 count.